WO1999030719A3 - Utilisation d'un oestrogene pour le traitement de la depression postnatale - Google Patents

Utilisation d'un oestrogene pour le traitement de la depression postnatale Download PDF

Info

Publication number
WO1999030719A3
WO1999030719A3 PCT/FR1998/002721 FR9802721W WO9930719A3 WO 1999030719 A3 WO1999030719 A3 WO 1999030719A3 FR 9802721 W FR9802721 W FR 9802721W WO 9930719 A3 WO9930719 A3 WO 9930719A3
Authority
WO
WIPO (PCT)
Prior art keywords
oestrogen
postnatal depression
treating postnatal
treating
depression
Prior art date
Application number
PCT/FR1998/002721
Other languages
English (en)
Other versions
WO1999030719A2 (fr
Inventor
Benoit Agnus
Antoine Besins
Original Assignee
Besins Iscovesco Lab
Benoit Agnus
Antoine Besins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Iscovesco Lab, Benoit Agnus, Antoine Besins filed Critical Besins Iscovesco Lab
Priority to AU15683/99A priority Critical patent/AU1568399A/en
Publication of WO1999030719A2 publication Critical patent/WO1999030719A2/fr
Publication of WO1999030719A3 publication Critical patent/WO1999030719A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Abstract

L'invention a pour objet l'utilisation d'un oestrogène pour la fabrication d'un gel destiné au traitement de la dépression postnatale.
PCT/FR1998/002721 1997-12-15 1998-12-14 Utilisation d'un oestrogene pour le traitement de la depression postnatale WO1999030719A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15683/99A AU1568399A (en) 1997-12-15 1998-12-14 Use of an oestrogen for treating postnatal depression

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715887A FR2772270B1 (fr) 1997-12-15 1997-12-15 Utilisation d'un oestrogene pour le traitement de la depression postnatale
FR97/15887 1997-12-15

Publications (2)

Publication Number Publication Date
WO1999030719A2 WO1999030719A2 (fr) 1999-06-24
WO1999030719A3 true WO1999030719A3 (fr) 1999-08-19

Family

ID=9514630

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/002721 WO1999030719A2 (fr) 1997-12-15 1998-12-14 Utilisation d'un oestrogene pour le traitement de la depression postnatale

Country Status (3)

Country Link
AU (1) AU1568399A (fr)
FR (1) FR2772270B1 (fr)
WO (1) WO1999030719A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011252763B2 (en) * 2010-05-14 2012-12-20 Charlotte L. Keating A method of treatment and diagnosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518879A1 (fr) * 1981-12-30 1983-07-01 Besins Jean Medicament a base d'oestradiol pour le traitement de la pathologie menopausique
EP0409383A2 (fr) * 1989-07-21 1991-01-23 Izhak Blank Compositions à base d'estradiol et procédés d'application topique
EP0573133A1 (fr) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Application transdermique contenant du Gestoden

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518879A1 (fr) * 1981-12-30 1983-07-01 Besins Jean Medicament a base d'oestradiol pour le traitement de la pathologie menopausique
EP0573133A1 (fr) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Application transdermique contenant du Gestoden
EP0409383A2 (fr) * 1989-07-21 1991-01-23 Izhak Blank Compositions à base d'estradiol et procédés d'application topique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GREGOIRE, A.J.P. ET AL: "Transdermal oestrogen fo treatment of severe postnatal depression", THE LANCET, vol. 347, no. 9006, 6 April 1996 (1996-04-06), pages 930 - 933, XP002075481 *

Also Published As

Publication number Publication date
FR2772270B1 (fr) 2002-06-07
AU1568399A (en) 1999-07-05
FR2772270A1 (fr) 1999-06-18
WO1999030719A2 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
EP1400523A3 (fr) Composés intermédiaires
ZA971397B (en) Undercutting surgical instrument.
MX9800401A (es) Sistema transcorneal de liberacion de medicamentos.
HK1031942A1 (en) Card activation at point of distribution.
ZA989058B (en) Snack.
ZA985569B (en) Polymerisation process.
AU5655896A (en) Validation
EP0831098A3 (fr) Produits intermédiaires et procédé pour la préparation d'olanzapine
WO1999032509A3 (fr) Analogues d'hemiasterline
ZA966773B (en) Sulfonyl-or sulfinyl-benzoylguanidin derivate.
AU1437099A (en) Method for generating over-pressure gas
ZA978930B (en) Trim shoe.
ZA986885B (en) A process for the preparation of cyclopropylacetylene.
ZA9710114B (en) Method for the expression of genes.
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
WO1998032863A3 (fr) Thioredoxine mammalienne
WO1999030719A3 (fr) Utilisation d'un oestrogene pour le traitement de la depression postnatale
ZA964565B (en) Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
ZA98225B (en) Polymerisation process.
AU2387597A (en) Process for the hydroxylation of 1,4-dichlorobenzene
AU1095199A (en) High pressure regulator
AU5290496A (en) Pressure converter (b)
AUPO610397A0 (en) An improved lock-nut
AUPP375198A0 (en) An anticorrosion treatment
AU8450198A (en) System for generating sub-keys

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 09268352

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)

Free format text: (EXCEPT US)

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA